Dr. Michelle Perugini is an entrepreneur and AI leader with deep expertise in healthcare. She has a PhD in Medicine, a decade of oncology research experience, and has founded two global AI tech companies—one acquired by EY in 2015.
As Co-Founder and former CEO of Presagen, Michelle developed a Federated AI platform for medical data, with its flagship product, Life Whisperer, improving IVF outcomes before being acquired by Astec in 2024.
Michelle is now Co-Founder and Board Chair of Qubigen, focusing on AI-driven drug design, and serves at UniSA as Head of Commercialisation and CEO of UniSA Ventures.